首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmacopsychiatry

缩写:PHARMACOPSYCHIATRY

ISSN:0176-3679

e-ISSN:1439-0795

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引779
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
T Wobrock,T Schneider-Axmann,W Retz et al. T Wobrock et al.
Introduction: Abnormalities in corticosubcortical circuits in schizophrenia have been described by previous neuroimaging and electrophysiological studies. Previous studies assessing excitability of the motoneural system b...
C Waldschmitt,F Vogel,B Pfuhlmann et al. C Waldschmitt et al.
Introduction: The aim of this study was to relate drug concentrations in serum and clinical effects in patients treated with the new antidepressant duloxetine. ...
C Song,U Halbreich,C Han et al. C Song et al.
Background: An increase in inflammatory response and an imbalance between T-helper (Th) 1 and 2 functions have been implicated in major depression. The aims of the present study were to 1) study the relationship between p...
B Croissant,S Loeber,A Diehl et al. B Croissant et al.
Introduction: Oxcarbazepine (OXC), a derivative of Carbamazepine (CBZ), may represent a solution to metabolic and side effects of CBZ treatment due to the fact that renal excretion is its major route of elimination. The g...
U Hegerl,C Sander,S Olbrich et al. U Hegerl et al.
Mania and attention-deficit hyperactivity disorder (ADHD) show a high degree of symptom overlap and comorbidity. Clinical trials and case reports indicate that psychostimulants do not or only rarely trigger or aggravate manic episodes but c...
J Berwaerts,A Cleton,V Herben et al. J Berwaerts et al.
Introduction: Co-morbid medical and psychiatric conditions are common in individuals with schizophrenia. As such, selecting antipsychotic medications with a low potential for drug-drug interactions (DDIs) is crucial, as m...
C J Bachmann,D Lehr,F M Theisen et al. C J Bachmann et al.
Introduction: Combination of antipsychotic substances is a therapeutic option increasingly applied in patients with schizophrenia, who do not respond to antipsychotic monotherapy. Recently, various reports on combination ...
D Novick,A Gonzalez-Pinto,J M Haro et al. D Novick et al.
Objectives: The aim of this study was to compare the outcomes of olanzapine- and valproate-treated patients in an observational study of acute mania with the results of a randomised controlled trial (RCT) assessing the sa...